COMPUGROUP MEDICAL SE & CO. KGAA CompuGroup Medical confirms guidance and mid-term growth targets at virtual Annual General Meeting

Directive transparence : information réglementée

19/05/2021 13:46

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): AGM/EGM
CompuGroup Medical confirms guidance and mid-term growth targets at virtual Annual General Meeting

19.05.2021 / 13:46
The issuer is solely responsible for the content of this announcement.

Koblenz. CompuGroup Medical SE & Co. KGaA - one of the leading e-health companies in the world - today successfully held its virtual Annual General Meeting (AGM). The resolutions on the dividend payment, the purchase and use of treasury shares, the remuneration system and the discharge of the executive and supervisory boards were passed with convincing majorities. The management confirmed the guidance for the current year and mid-term growth targets.

The attendance at today's AGM, which was held as a virtual meeting for the second time due to the ongoing COVID-19 pandemic, was about 83 % of total share capital. The resolution on the appropriation of profits including the proposed dividend of EUR 0.50 was passed with a majority of 99.9 %. The AGM also passed resolutions on the approval of the actions of the former Management Board, the current General Partner and the former and the current Supervisory Boards, the purchase and use of treasury shares and the remuneration system for the Managing Directors and Supervisory Board, each with convincing majorities of more than 75 % of the votes.

"CompuGroup Medical achieved record revenues of EUR 837 million in the financial year 2020 - a remarkable increase of 12 %. At the same time, the adjusted EBITDA increased by 8 % to EUR 215 million," said CEO Dr. Dirk Wössner and added, "Worldwide, the COVID-19 pandemic has proven in a dramatic way how crucial well-functioning, efficient healthcare is, and which opportunities arise from digitization of the processes, data processing and information exchange. Many governments have recognized the urgent need for action and have set up large investment programs in the billions, in some cases."

In his speech, Dirk Wössner confirmed the guidance for the current financial year, envisaging more than EUR 1 billion in revenues and an adjusted EBITDA in the range of EUR 210 - 230 million. And he emphasized that CGM is targeting significant growth in the future from enhancing services for healthcare professionals with new functionalities, patient portals, synergies and scale effects from the two large acquisitions in the hospital business and the US market, from additional modules in Telematics Infrastructure, new data services and by digitization initiatives such as the Hospital Future Act in Germany.

Dirk Wössner: "Beyond 2021, we expect annual organic revenue growth of 5 % and more with the EBITDA margin increasing again at the same time."

Information on the AGM including the full voting results is available at www.cgm.com/agm.

About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among e-health service providers. Approximately 8,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for media representatives:
Michael Franz
Head of Brand Communication
P +49 (0) 261 8000-6100
F +49 (0) 261 8000-3100
E-mail: press@cgm.com

Contact for analysts and investors:
Claudia Thomé
Corporate Vice President Investor Relations
P +49 (0) 261 8000-7030
F +49 (0) 261 8000-3200
E-mail: claudia.thome@cgm.com

19.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1198437

End of News DGAP News Service

1198437  19.05.2021